CVE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cenovus Energy Inc (CVE) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite some mixed signals in technical analysis and analyst ratings, the company's strong financial performance in the latest quarter, positive news sentiment, and favorable options data suggest growth potential. Additionally, the company's dividend payments and redemption of preferred shares indicate shareholder alignment and financial stability.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. However, the MACD is negative and expanding, which may suggest short-term weakness. RSI is neutral at 53.412, and the stock is trading near its pivot level of 22.215, with support at 21.329 and resistance at 23.1.
The company announced the redemption of preferred shares and declared dividends, which may boost investor confidence.
Analysts from RBC Capital, BMO Capital, and TD Securities have raised price targets, with several maintaining 'Outperform' or 'Buy' ratings.
Net income and EPS saw significant YoY growth in Q4 2025, indicating strong profitability.
Veritas downgraded the stock to 'Sell,' and JPMorgan downgraded it to 'Neutral,' citing supply-side risks and relative valuations.
Revenue dropped by 7.35% YoY in Q4 2025, which could raise concerns about growth sustainability.
MACD is negative, which may indicate short-term bearish momentum.
In Q4 2025, Cenovus Energy reported a revenue drop of 7.35% YoY to $10.88 billion. However, net income surged by 580.29% YoY to $932 million, and EPS increased by 614.29% YoY to 0.5. Gross margin improved to 25.24%, up 11.09% YoY, reflecting strong profitability despite revenue challenges.
Analyst ratings are mixed. While RBC Capital, BMO Capital, and TD Securities raised price targets to C$32-C$35 with 'Outperform' or 'Buy' ratings, Veritas downgraded the stock to 'Sell,' and JPMorgan downgraded it to 'Neutral.' The consensus indicates optimism from most analysts, but some concerns remain regarding supply-side risks and valuation.
